Company Filing History:

8 out of 48

Sibia Neurosciences, Inc.

patents

4 out of 164

Amylin Pharmaceuticals, Inc.

4. 1 out of 832,761

Other

patents

Years Active: 1995-2007

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7271238 - Amylin agonist peptides and uses therefor (2007-09-18),

2. 6610824 - Amylin agonist peptides and uses therefor (2003-08-26),

3. 6051684 - Methods of treating neurodegenerative disorders using protease inhibitors (2000-04-18),

4. 6017887 - Peptide, peptide analog and amino acid analog protease inhibitors (2000-01-25),

5. 6015879 - Peptide and peptide analog protease inhibitors (2000-01-18),

6. 5998367 - Pramlintide pro H-amylin salts and compositions (1999-12-07),

7. 5969100 - Peptide, peptide analog and amino acid analog protease inhibitors (1999-10-19),

8. 5962419 - Peptide and peptide analog protease inhibitors (1999-10-05),

9. 5872101 - Methods of treating neurodegenerative disorders using protease inhibitors (1999-02-16),

10. 5863902 - Methods of treating neurodegenerative disorders using protease inhibitors (1999-01-26),

11. 5804560 - Peptide and peptide analog protease inhibitors (1998-09-08),

12. 5686411 - Amylin agonist peptides and uses therefor (1997-11-11),

13. 5580953 - Amylin antagonist peptides and uses therefor (1996-12-03),

14. 5424394 - Synthetic preparation of amylin and amylin analogues (1995-06-13),

Title: The Innovative Contributions of Elisabeth Albrecht

Introduction

Elisabeth Albrecht is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of diabetes and related conditions. With a total of 14 patents to her name, her work has had a profound impact on medical science.

Latest Patents

Among her latest patents are groundbreaking developments in amylin agonist peptides. These patents include agonist analogues of amylin and related pharmaceutical compositions, which provide methods for treating diabetes and other insulin-requiring states. Additionally, her work addresses methods for treating hypoglycemia, showcasing her commitment to advancing healthcare solutions.

Career Highlights

Elisabeth has worked with notable companies such as Sibia Neurosciences, Inc. and Amylin Pharmaceuticals, Inc. Her experience in these organizations has allowed her to collaborate with leading experts in the field, further enhancing her innovative capabilities.

Collaborations

Some of her notable coworkers include Ian A McDonald and Benito Munoz. Their collaborative efforts have contributed to the success of her projects and the advancement of medical treatments.

Conclusion

Elisabeth Albrecht's contributions to the field of pharmaceuticals through her innovative patents and collaborations highlight her as a key figure in medical research. Her work continues to influence the treatment of diabetes and related conditions, making a lasting impact on healthcare.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com